# Ablation Verses Anti-arrhythmic Therapy for Reducing All Hospital Episodes From Recurrent Atrial Fibrillation

> **NCT02459574** · NA · COMPLETED · sponsor: **Imperial College London** · enrollment: 321 (actual)

## Conditions studied

- Heart Failure
- Recurrent Atrial Fibrillation

## Interventions

- **PROCEDURE:** AVATAR-AF ablation
- **DRUG:** Anti-Arrhythmic therapy
- **PROCEDURE:** Conventional AF ablation

## Key facts

- **NCT ID:** NCT02459574
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05-01
- **Primary completion:** 2018-09-30
- **Final completion:** 2018-11-27
- **Target enrollment:** 321 (ACTUAL)
- **Last updated:** 2024-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02459574

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02459574, "Ablation Verses Anti-arrhythmic Therapy for Reducing All Hospital Episodes From Recurrent Atrial Fibrillation". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT02459574. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*